Solution structure of the antiapoptotic protein bcl-2

被引:366
作者
Petros, AM
Medek, A
Nettesheim, DG
Kim, DH
Yoon, HS
Swift, K
Matayoshi, ED
Oltersdorf, T
Fesik, SW
机构
[1] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA
[2] IDUN Pharmaceut, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.041619798
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The structures of two isoforms of Bcl-2 that differ by two amino acids have been determined by NMR spectroscopy. Because wildtype Bcl-2 behaved poorly in solution, the structures were determined by using Bcl-2/Bcl-x(L) chimeras in which part of the putative unstructured loop of Bcl-2 was replaced with a shortened loop from Bcl-x(L). These chimeric proteins have a low pi compared with the wild-type protein and are soluble. The structures of the two Bcl-2 isoforms consist of 6 alpha -helices with a hydrophobic groove on the surface similar to that observed for the homologous protein, Bcl-x(L). Comparison of the Bcl-2 structures to that of Bcl-x(L) shows that although the overall fold is the same, there are differences in the structural topology and electrostatic potential of the binding groove. Although the structures of the two isoforms of Bcl-2 are virtually identical, differences were observed in the ability of the proteins to bind to a 25-residue peptide from the proapoptotic Bad protein and a 16-residue peptide from the proapoptotic Bak protein. These results suggest that there are subtle differences in the hydrophobic binding groove in Bcl-2 that may translate into differences in antiapoptotic activity for the two isoforms.
引用
收藏
页码:3012 / 3017
页数:6
相关论文
共 47 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies [J].
Anderson, M ;
Blowers, D ;
Hewitt, N ;
Hedge, P ;
Breeze, A ;
Hampton, I ;
Taylor, L .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 15 (02) :162-170
[3]   CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18 [J].
BAKHSHI, A ;
JENSEN, JP ;
GOLDMAN, P ;
WRIGHT, JJ ;
MCBRIDE, OW ;
EPSTEIN, AL ;
KORSMEYER, SJ .
CELL, 1985, 41 (03) :899-906
[4]   Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated [J].
Berghella, AM ;
Pellegrini, P ;
Contasta, I ;
Del Beato, T ;
Adorno, D .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (04) :225-237
[5]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[6]  
Brunger A.T., 1992, X PLOR VERSION 3 1 M
[7]  
CAMPOS L, 1993, BLOOD, V81, P3091
[8]   RIBBON MODELS OF MACROMOLECULES [J].
CARSON, M .
JOURNAL OF MOLECULAR GRAPHICS, 1987, 5 (02) :103-&
[9]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[10]   CLONING AND STRUCTURAL-ANALYSIS OF CDNAS FOR BCL-2 AND A HYBRID BCL-2/IMMUNOGLOBULIN TRANSCRIPT RESULTING FROM THE T(14-18) TRANSLOCATION [J].
CLEARY, ML ;
SMITH, SD ;
SKLAR, J .
CELL, 1986, 47 (01) :19-28